Dr. Agarwal’s Health Care IPO subscribed overall1.49 times on the last day, while a retail quota was subscribed 0.42 times and QIB was 4.41 and NII 0.39 respectively.
Details about Dr. Agarwal’s Health Care’s IPO
Dr. Agrwal Healthcare Care is one of the leading firms for eye care-related pharmaceutical products, for its excellent financial background it has filed DRHP and got a green light from SEBI for an IPO of Rs ₹3,027.26 Crores. Moreover, it was a combination of fresh issue and OFS, while the fresh issue was Rs ₹300 Crores and OFS was Rs 6,78,42,284 Equity Shares.
- An IPO is considered 35 shares in 1 lot size for retailers(Min)
- Moreover, 490 shares were in 13 lot sizes for retailers (Max)
- 525 shares in 14 lot size S-HNI
- 2,520 shares in 68 lot size B-HNI
To invest in this IPO, each investor category has specific investment amounts:
- Retail Investors: Minimum investment of ₹14,070
- Retail investors: maximum investment of ₹1,96,980
- Small HNI (S-HNI): Minimum investment of ₹2,11,050
- Big HNI(B-Hni): Maximum Investment of ₹10,13,040
Subscription duration of Dr. Agarwal’s Health Care
- IPO started on January 29, 2025, till 23rd January 31, 2025
- The allotment will be available on February 3, 2025, and the IPO listing is on February 5, 2025
Funds Deployment of This IPO
- Repayment/prepayment of the borrowings
- General corporate purposes and unidentified inorganic acquisition
About Dr. Agarwal’s Health Care Company
Dr. Agarwal’s Health Care Limited, founded in 2010, is a growing company in the eye care industry. They offer a wide range of products and services, including cataract and refractive surgeries, eye consultations, diagnoses, non-surgical treatments, optical products, contact lenses, and accessories.
As of March 31, 2024, the company comprises around 180 facilities. The Sale of optical, contact lenses, and accessories are some of the eye care-related products they sell come under Primary facilities.
In India, they have a strong presence with 26 major centers, including three Centers of Excellence (COEs). Additionally, they operate 139 smaller locations, consisting of 35 primary and 104 secondary facilities
Dr. Agarwal’s Health Care IPO Financial Background
The company shows revenue of ₹1,376.45 crores in 2024 against ₹1,031.49 crores in 2023. The company reported a profit of ₹95.05 crores in 2024, compared to ₹103.23 crores in 2023.